# Alexander Stratigos

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alexander-stratigos/

## Facts

| Field | Value |
| --- | --- |
| Citations | 13,935 |
| Field | Cutaneous Melanoma Detection and Management |
| h-index | 59 |
| i10-index | 187 |
| Last Known Institution | National and Kapodistrian University of Athens |
| OpenAlex ID | https://openalex.org/A5002280676 |
| ORCID iD | 0000-0002-6088-5694 |
| Works | 396 |

## Researcher papers

- [Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines](https://scholariq.org/papers/diagnosis-and-treatment-of-basal-cell-carcinoma-european-consensus-based/)
- [Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016](https://scholariq.org/papers/diagnosis-and-treatment-of-melanoma-european-consensus-based-interdisciplinary/)
- [Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline](https://scholariq.org/papers/diagnosis-and-treatment-of-invasive-squamous-cell-carcinoma-of-the-skin-european/)
- [Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline](https://scholariq.org/papers/diagnosis-and-treatment-of-merkel-cell-carcinoma-european-consensus-based/)
- [Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial](https://scholariq.org/papers/treatment-with-two-different-doses-of-sonidegib-in-patients-with-locally/)
- [Diagnostic delay in hidradenitis suppurativa is a global problem](https://scholariq.org/papers/diagnostic-delay-in-hidradenitis-suppurativa-is-a-global-problem/)
- [European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment](https://scholariq.org/papers/european-interdisciplinary-guideline-on-invasive-squamous-cell-carcinoma-of-the/)
- [European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023](https://scholariq.org/papers/european-consensus-based-interdisciplinary-guideline-for-diagnosis-and-treatment/)
- [Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial](https://scholariq.org/papers/cemiplimab-in-locally-advanced-basal-cell-carcinoma-after-hedgehog-inhibitor/)
- [Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility](https://scholariq.org/papers/genome-wide-association-meta-analyses-combining-multiple-risk-phenotypes-provide/)
- [Unveiling the Impact of Moderate and Severe Atopic Dermatitis: Insights on Burden, Clinical Characteristics, and Healthcare Resource Utilization in Adult Greek Patients from the APOLO Cross-Sectional Study](https://scholariq.org/papers/unveiling-the-impact-of-moderate-and-severe-atopic-dermatitis-insights-on-burden/)

## Researcher topics

- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Nonmelanoma Skin Cancer Studies](https://scholariq.org/topics/nonmelanoma-skin-cancer-studies/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [melanin and skin pigmentation](https://scholariq.org/topics/melanin-and-skin-pigmentation/)
- [Skin Protection and Aging](https://scholariq.org/topics/skin-protection-and-aging/)

## Researcher university

- [National and Kapodistrian University of Athens](https://scholariq.org/institutions/national-and-kapodistrian-university-of-athens/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.